Trial Profile
The Effect of Intravitreous Ranibizumab on Intra-Operative Bleeding During Pars Plana Vitrectomy for Diabetic Traction Retinal Detachment.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Sep 2010
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic retinopathy; Vitreous haemorrhage
- Focus Therapeutic Use
- Acronyms RANITRA
- 23 Sep 2010 New trial record